2007
DOI: 10.1097/cad.0b013e32809ef9d0
|View full text |Cite
|
Sign up to set email alerts
|

The efficiency of a PAMAM dendrimer toward the encapsulation of the antileukemic drug 6-mercaptopurine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
16
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(16 citation statements)
references
References 14 publications
0
16
0
Order By: Relevance
“…In this study, we have demonstrated that similar to the complexation of other hydrophobic drugs using dendrimers,2224 2-ME can also be complexed within dendrimers having different terminal groups (Scheme 1). The formation of 2-ME/dendrimer complexes is primarily based on hydrophobic interactions between dendrimers and 2-ME drug molecules.…”
Section: Resultsmentioning
confidence: 77%
“…In this study, we have demonstrated that similar to the complexation of other hydrophobic drugs using dendrimers,2224 2-ME can also be complexed within dendrimers having different terminal groups (Scheme 1). The formation of 2-ME/dendrimer complexes is primarily based on hydrophobic interactions between dendrimers and 2-ME drug molecules.…”
Section: Resultsmentioning
confidence: 77%
“…3 4 Several reports indicated that anticancer drugs (camptothecin, 6-mercaptopurin, methotrexate, adriamycin, 5-fluorouracil, and paclitaxel) were encapsulated into the PAMAM dendrimer exhibiting a significant enhancement of its water solubility, storage stability, and anti-tumor activity. [5][6][7][8][9][10] However, there are a few disadvantages accompanied with PAMAM dendrimer drug-delivery system including hemolytic toxicity and cell lysis due to a strong interaction of the positively charged dendrimer and the negatively charged cell membrane resulting in membrane disruption. 9 11-13 Like other cationic polymers such as polylysine and poly(ethyleneimine), these disadvantages have been solved by conjugating biocompatible and hydrophilic polymers into amine group-terminated dendrimer.…”
Section: Introductionmentioning
confidence: 99%
“…mercaptopurin, methotrexate, 5-FU, and paclitaxel) were encapsulated into the PAMAM dendrimer exhibiting a significant enhancement of its water solubility, storage stability, reduction of side-effects, and anti-tumor activity [17][18][19][20][21]. However, there are a few disadvantages accompanied with the amine-terminated dendrimer-based carriers including hemolytic toxicity and cell lysis due to a strong interaction of its positively charge and a negative charge on cell membrane resulting in disruption of the cellular membrane [22][23][24][25][26].…”
Section: Introductionmentioning
confidence: 99%